Holmusk
PrivateLast Round
Strategic
Oct 2, 2023
Total Funding Raised
$106.25M
Company Overview
Holmusk operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Strategic round in October 2023.
Holmusk is a health technology company that provides a data analytics platform to transform research and care for behavioral health.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Mental Health, EHR & EMR, NLP & Conversational AI, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Holmusk Comparables
Compare Holmusk with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OM1 | 84% | |
| Akrivia Health | 83% | |
| nference | 76% |
For institutional investors. Book with your work email.
Holmusk Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 2, 2023 | ||||
| Series B | Jan 9, 2023 | ||||
| Series A Extension | Dec 6, 2021 | ||||
| Series A | May 18, 2020 | ||||
| Early Funding | Sep 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Holmusk Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dRx Capital | Series B, Series A Extension |
| Heritas Capital Management | Series A Extension, Series B, Early Funding, Series A |
| Singapore Health Management | Series A |
| Health Catalyst Capital Management | Series B, Series A Extension, Series A |
| NTAsset | Early Funding |
| Optum Ventures | Series A, Series A Extension |
| Northwell Holdings | Series B, Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2018
$9.75M raised led by Octave Capital.
For institutional investors. Book with your work email.
Holmusk Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Holmusk's valuation, stock price, and market status.
Is Holmusk a public or private company?
Holmusk is a private company.
What is the current stock price of Holmusk?
Holmusk is a private company, so its shares have no public market price. Caplight tracks Holmusk's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Holmusk worth (valuation)?
Valuation information for Holmusk is not publicly available.
Can I buy Holmusk stock?
Holmusk shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Holmusk's last funding round?
Holmusk's most recent funding round was Strategic on October 2, 2023.
Who are the main investors in Holmusk?
Key investors in Holmusk include dRx Capital, Health Catalyst Capital Management, Optum Ventures.
Will Holmusk IPO soon?
No public IPO plans have been announced for Holmusk.
How can I track Holmusk secondary market activity?
Caplight tracks bids, offers, and trades in Holmusk's shares on secondary markets.